23 Jul 2018

Bayer Pulls Essure From the Market

Bayer has announced it will stop selling Essure in the United States at the end of the year. The move comes after the FDA restricted the sale and distribution of the device across the country, which Bayer has committed to continue to ensure that females are fully informed of the increased risks that have been associated with the birth control device.

On April 9, 2018, the FDA issued a sales restriction for Essure so that only physicians who were willing to share an information brochure and get a signed acceptance of risk form from patients could implant the device. Patients who signed the packet were informed of the serious side effects of the drug as well as severe adverse events. Women allege they have been suffering great harm from the device, and many have had to undergo hysterectomies and fallopian tube removal in an effort to stem the side effects and resulting complications of the device.

Read the full FDA report here

If you received the Essure birth control device and suffered serious side effects and complications, you may be eligible for compensation. Contact us today for a free case evaluation.

Bayer Pulls Essure From the Market
5 (100%) 2 votes